Claudin-2 Promotes Breast Cancer Liver Metastasis by Facilitating Tumor Cell Interactions with Hepatocytes

Hepatocyte induced re-expression of E-cadherin in breast and prostate cancer cells increases chemoresistance

(2011) Yvonne Chao et al.   CLINICAL & EXPERIMENTAL METASTASIS

The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs

(2011) Robert R. Langley et al.   INTERNATIONAL JOURNAL OF CANCER

Rethinking the metastatic cascade as a therapeutic target

(2011) Lida A. Mina et al.   Nature Reviews Clinical Oncology

Claudin-2 expression increases tumorigenicity of colon cancer cells: role of epidermal growth factor receptor activation

(2011) P Dhawan et al.   ONCOGENE

Claudins and tricellulin in fibrolamellar hepatocellular carcinoma

(2011) Attila Patonai et al.   VIRCHOWS ARCHIV

Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers

(2010) Qin Yao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer

(2010) Emiliano Cocco et al.   BMC CANCER

Prognostic significance of claudin expression changes in breast cancer with regional lymph node metastasis

(2010) A. M. Szasz et al.   CLINICAL & EXPERIMENTAL METASTASIS

Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin

(2010) Hideki Kakutani et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

The Claudin family and its role in cancer and metastasis

(2010) Astrid Escudero-Esparza   Frontiers in Bioscience-Landmark

Claudin-2, a component of the tight junction, forms a paracellular water channel

(2010) R. Rosenthal et al.   JOURNAL OF CELL SCIENCE

Interactions between colon cancer cells and hepatocytes in rats in relation to metastasis

(2010) O. R. F. Mook et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A Claudin-Targeting Molecule as an Inhibitor of Tumor Metastasis

(2010) R. Saeki et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The Expression of Claudin-1, Claudin-2, Claudin-3, and Claudin-4 in Gastric Cancer Tissue

(2010) Hun Jung et al.   JOURNAL OF SURGICAL RESEARCH

Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition

(2010) Yvonne L Chao et al.   Molecular Cancer

Molecular mechanisms of metastasis in breast cancer—clinical applications

(2010) Michal Mego et al.   Nature Reviews Clinical Oncology

Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes

(2010) S Tabariès et al.   ONCOGENE

ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties

(2010) April A. N. Rose et al.   PLoS One

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

(2009) X. Yuan et al.   MOLECULAR CANCER THERAPEUTICS

Keratin–protein kinase C interaction in reactive oxygen species-induced hepatic cell death through mitochondrial signaling

(2008) Jasmin Mathew et al.   FREE RADICAL BIOLOGY AND MEDICINE

Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease

(2008) T H Kim et al.   HISTOPATHOLOGY

Kinetics of Adhesion Mediated by Extracellular Loops of Claudin-2 as Revealed by Single-Molecule Force Spectroscopy

(2008) Tong Seng Lim et al.   JOURNAL OF MOLECULAR BIOLOGY

Transforming growth factor-β inhibits telomerase through SMAD3 and E2F transcription factors

(2007) Annie Lacerte et al.   CELLULAR SIGNALLING

Formation of tight junction: determinants of homophilic interaction between classic claudins

(2007) Jörg Piontek et al.   FASEB JOURNAL